Metrohm is pleased to announce the acquisition of Innovative Photonic Solutions (IPS). With this important acquisition, Metrohm continues to invest in strategic growth and enhances the company’s capabilities to further develop a portfolio of industry-leading Raman solutions.IPS is the largest producer of Raman spectroscopy diode-based light components in the world. Founded in 2003, the company’s products range from simple components such as packaged diodes and OEM modules that include....

Ingenza has joined forces with leading universities and industrial partners to participate in the ConBioChem collaboration, a translational project focused on the development of novel platform technologies for the continuous bio-production of commodity chemicals. The consortium, led by Professor Gill Stephens of the University of Nottingham, recently achieved success in the Industrial Biotechnology Catalyst – a multi-million pound competition funded by Innovate UK, BBSRC and EPSRC – resulting in the award of £3.46 million over a five-year period....

Powder characterisation specialists, Freeman Technology, will be exhibiting at Analytica for the first time in Hall A2 Stand 423 (10 – 13 April 2018, Muenchen, Germany). With a direct operation now established in Germany, the company will be showcasing their material characterisation solutions designed to optimise process performance, increase productivity and improve quality in a diverse range of sectors....

SYGNIS AG has announced it has extended the manufacturing capability for its Lightning-Link^® technology, currently marketed under the Innova Biosciences brand, to support scalability and bulk production of antibodies.

Lightning-Link is an innovative technology that enables direct labeling of antibodies or proteins in as little as 20 minutes, for use in R&D applications, drug discovery and the development of diagnostic kits. Lightning-Link kits are the world’s fastest, easiest to use and most efficient method of labeling antibodies....

TIDE detects genome editing-mediated indels and calculates the efficiency of CRISPR using Sanger DNA sequencing data

Desktop Genetics Ltd (DTG), a biotech company globally recognised for its leadership in gene-editing bioinformatics, acquired exclusive worldwide licensing rights for TIDE (Tracking of Indels by DEcomposition), from the Netherlands Cancer Institute (NKI)....

Global chromatography syringes market is expected to reach USD 178.1 million by 2022, at a CAGR of 5.7% during the forecast period of 2017 to 2022.

The growth of this market is mainly attributed by the increasing investment and funding for life sciences research, growing use of chromatography techniques in drug approval, increased funding for chromatography technologies by regional governments, various technological advancements, and increasing investments by the major players in emerging markets....

This year, BMG LABTECH’s Australian office celebrates 20 years of innovation and steady growth.

The office was established in January 1998 to support Australia and the APAC region, offering excellent sales and customer service for BMG LABTECH’s wide range of dedicated and multi-mode microplate readers. “Since its incorporation there have been many changes at BMG LABTECH....

Save more money with Pop-Bio Pop-Bio, the fast-growing Cambridge based company, offer a number of its family of brands to the life science market. Launched at the end of 2016, Pop-Bio has established itself as central point for its sister company brands of Vivantis, Hercuvan and Stemmera. Additionally, from April 2018, Pop-Bio will also be launching a brand new product for gel and blot imaging using its latest patented technologies.....

Topics of this year's Conferee Networking sessions span a variety of topics from the discussion of specific laboratory techniques to the role of social media in science.

The Pittcon Organizing Committee recently released the topics for Conferee Networking during Pittcon 2018, which will be in Orlando, Florida, February 26-March 1.  Conferee Networking sessions provide an informal environment where participants can meet and discuss similar interests...

Abzena plc has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.

Abzena has selected Sartorius Stedim to equip its integrated CDMO facilities in Bristol, PA (development and GMP manufacture of antibody drug conjugates) and San Diego, CA (development and GMP manufacture of monoclonal antibodies and other recombinant proteins......

ZEISS and BOSELLO HIGH TECHNOLOGY have announced that the ZEISS Group will acquire a majority stake in the provider of industrial X-ray solutions.

For ZEISS, BOSELLO’s tailor-made solutions are a further step in the process of evolving into a one-stop provider of non-destructive measuring and inspection technology. The shared goal is to strengthen inline computed tomography....

Next generation protein engineering technology for improved drug candidate decision making

ProImmune, a leader in services for understanding immune responses, has announced the introduction of MutaMap™, a new high-throughput assay service for understanding the impact of point mutations on protein therapeutic activity, including monoclonal antibodies....

Research into the potential use of microscopic nanoparticles called exosomes in the early detection of cancer has put research taking place at Discovery Park firmly in the spotlight.

Canterbury Christ Church University’s (CCCU) Life Science Industry Liaison Laboratory has linked up with the University of Liverpool, Roy Castle Lung Cancer Foundation and US science firm HTG Molecular Diagnostics for initial patient studies, ahead of a full clinical trial....

MediSapiens will provide its data curation, data management, data exploration and discovery software solutions to FinnGen, and will be an active technology partner in the project.

As the leading provider of end-to-end solutions for biomedical data, MediSapiens is able to support the FinnGen project with cutting edge solutions for analyzing, curating, managing, exploring, interpreting and visualizing the vast pool of genetic and clinical data gathered in the project...

Asynt announces “Asyntise” a consultation, design and manufacture service whereby the company collaborates with scientists to create practical tools to help fulfil their research needs.

These products may be in the form of one-off custom developments or, in some instances, may evolve into a commercial product suitable for a wider audience....

Fast Track Diagnostics’ (FTD) broad range of CE-marked infectious disease detection tests and syndromic panels¹ expands the Siemens Healthineers molecular diagnostics portfolio

FTD’s kits can distinguish between multiple infections through a single test. Siemens Healthineers has signed an agreement to acquire Luxembourg-based Fast Track Diagnostics (FTD), a global supplier of diagnostics tests that, unlike a clinical examination alone, can distinguish between viral, bacterial, or other infections in one test...

from AMETEK Brookfield, the world leader in viscosity measurement

AMETEK Brookfield, the world standard for viscosity measurement and control, offers its Practical Course on Viscosity Measurements. This popular course was created to help AMETEK Brookfield Viscometer users comprehend the functionality of their instrument, solve the mysteries of fluid behavior and Rheology...

Asynt announces “Asyntise” a consultation, design and manufacture service whereby the company collaborates with scientists to create practical tools to help fulfil their research needs.

These products may be in the form of one-off custom developments or, in some instances, may evolve into a commercial product suitable for a wider audience. Asyntise formalises the close link that Asynt have established with the international chemistry research community over the last 15 year....

Horizon Discovery Group plc announces that it has entered into an agreement with Roche Diagnostics to assist in the development of immunohistochemistry (IHC) assays.

Under the terms of the agreement, Horizon will develop and provide Reference Standard material expressing neurotrophic tropomyosin receptor kinase (NTRK) fusion biomarkers. NTRK gene rearrangements have recently emerged as promising targets for cancer therapy, and a number of novel compounds have been developed....

Nightingale Health has been nominated as a “Health Innovation” of the year finalist for the Health Awards 2018, an annual event focusing on the future vision of Finnish healthcare.

Nightingale will participate in the awards ceremony, held in Helsinki, as part of the Foresight Forum in January 2018. “We’re proud to have received recognition from the Health Awards jury for our impact on the current debate taking place in the Finnish healthcare sector....

Horizon 2020 awarded to expedite the development of a 1GPixel resolution ultra-large format aerial surveillance camera.

Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020).  Horizon 2020 is a flagship initiative aimed at securing Europe's global competitiveness....

LAUDA is a global leader in precision temperature control in medical technology, material testing, bio-technology, laboratories, research and production.

A new corporate design is intended to portray the uncompromising quality and comprehensive expertise of LAUDA all over the world. The company image has been completely overhauled by Munich branding agency Martin et Karczinski adequately to represent LAUDA’s market position...